FDA Warns Of Risks To Babies From HIV Drug Kaletra
The U.S. Food and Drug Administration issued new warnings last month for Abbott Laboratories' Kaletra after serious health problems were reported in premature babies receiving the oral anti-HIV drug....To view the full article, register now.
Already a subscriber? Click here to view full article